Skip to main content

Find Clinical Trials

Home
Conditions
Venous Thromboembolism

Clinical trial condition

Venous Thromboembolism

Explore clinical trials studying Venous Thromboembolism. Study availability and eligibility vary by location and protocol.

528 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Venous Thromboembolism trial results

Completed

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4

NCT01120535

Conditions: Cardiovascular Diseases, Embolism, Embolism and Thrombosis, +6 more
Locations: Royal Brisbane Womens Hospital Brisbane, Australia

The Alfred Hospital Melbourne, Australia

Auckland City Hospital Auckland, New Zealand

View Trial Details

Completed

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3")

NCT01120522

Conditions: Cardiovascular Diseases, Embolism, Embolism and Thrombosis, +6 more
Locations: Imelda Hospital Bonheiden, Belgium

A. Z. St. Blasius Hospital Dendermonde, Belgium

View Trial Details

Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

NCT00558259

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: 1160.63.01025 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

1160.63.01023 Boehringer Ingelheim Investigational Site Huntsville, Alabama, United States

1160.63.01002 Boehringer Ingelheim Investigational Site Laguna Hills, California, United States

1160.63.01014 Boehringer Ingelheim Investigational Site Colorado Springs, Colorado, United States

View all 147 locations

View Trial Details

Completed

Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery

NCT02170935

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: Not specified

View Trial Details

Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: 1160.19.43004 Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria

1160.19.43002 Orthopädisches Spital Speising Vienna, Austria

1160.19.43001 A.ö. Krankenhaus d. Statutarstadt Wiener Neustadt Wiener Neustadt, Austria

1160.19.32002 V.U.B. Jette Brussels, Belgium

View all 59 locations

View Trial Details

Completed

Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

NCT01851239

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine Seoul, South Korea

View Trial Details

Completed

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

NCT01267305

Conditions: Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations: Zhongshan Hospital Shanghai, China

View Trial Details

Completed

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

NCT01277536

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: Kantonsspital Baden, Switzerland

University Hospitals Bern, Switzerland

Cantonal Hospital Fribourg, Switzerland

University Hospitals Geneva, Switzerland

View Trial Details

Completed

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

NCT00476216

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

NCT01139658

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations: Boehringer Ingelheim Investigational Site 30 Angers, France

Boehringer Ingelheim Investigational Site 41 Arles, France

Boehringer Ingelheim Investigational Site 40 Beauvais, France

Boehringer Ingelheim Investigational Site 2 Berck, France

View all 53 locations

View Trial Details